Jonathan A. Meulbroek
- Molecular Biology
- Pharmaceutical Science top 0.5%
- Immunology top 5%
- Infectious Diseases top 5%
- Epidemiology top 10%
- Co-authors
- Jay K. StaasThomas R. TiceRichard M. GilleyJohn H. EldridgeJerry R. McGheeZina MoldoveanuFritz G. BuchananMichael Coen
- Topics
- Advanced Drug Delivery Systems (4 papers)Immunotherapy and Immune Responses (3 papers)Antifungal resistance and susceptibility (2 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical OncologyJournal of Controlled Release
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Jonathan A. Meulbroek
17 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Molecular Biology 683
- Pharmaceutical Science 623
- Immunology 507
- Infectious Diseases 351
- Epidemiology 270
Countries citing papers authored by Jonathan A. Meulbroek
This map shows the geographic impact of Jonathan A. Meulbroek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan A. Meulbroek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan A. Meulbroek more than expected).
Fields of papers citing papers by Jonathan A. Meulbroek
This network shows the impact of papers produced by Jonathan A. Meulbroek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan A. Meulbroek. The network helps show where Jonathan A. Meulbroek may publish in the future.
Co-authorship network of co-authors of Jonathan A. Meulbroek
This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan A. Meulbroek. A scholar is included among the top collaborators of Jonathan A. Meulbroek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan A. Meulbroek. Jonathan A. Meulbroek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 136 | |
| 2 | 62 | |
| 3 | 14 | |
| 4 | 25 | |
| 5 | 4 | |
| 6 | 1 | |
| 7 | 24 | |
| 8 | 54 | |
| 9 | 17 | |
| 10 | 86 | |
| 11 | 6 | |
| 12 | 15 | |
| 13 | 332 | |
| 14 | 322 | |
| 15 | Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patchesbreakdown → | 588 |
| 16 | 169 | |
| 17 | 113 |
About Jonathan A. Meulbroek
Jonathan A. Meulbroek is a scholar working on Pharmaceutical Science, Molecular Medicine and Infectious Diseases, having authored 17 papers that have together received 2.0k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (4 papers), Immunotherapy and Immune Responses (3 papers) and Antifungal resistance and susceptibility (2 papers). The work is most often cited by research in Pharmaceutical Science (623 citations), Immunology (507 citations) and Endocrinology (109 citations). Jonathan A. Meulbroek has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Jay K. Staas, Thomas R. Tice, Richard M. Gilley, John H. Eldridge, Jerry R. McGhee, Zina Moldoveanu, Fritz G. Buchanan, Michael Coen, Aparna V. Sarthy and Peter J. DeVries. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.